Biophytis S.A. (ALBPS.PA) Stock Price

€0.176 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    6
  • Fundamental

    1
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Biophytis S.A., AI stock picks, stock alerts and much more.

Sign up

ALBPS.PA AI Stock Analysis

AI stock analysis for ALBPS.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Biophytis S.A. (ALBPS.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Biophytis S.A. (ALBPS.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Biophytis S.A. (ALBPS.PA), currently trading at €0.176, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ALBPS.PA

LSE
  • Biophytis S.

  • Symbol

    ALBPS.PA

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    4.1M

Similar Stocks

VLA.PA Valneva SE
VLA.PA
€5.05
2.4%
5
TUB.BR Financière de Tubize SA
TUB.BR
€160.6
0.4%
8
OSE.PA OSE Immunotherapeutics SA
OSE.PA
€6.32
0.5%
6
UCB.BR UCB SA
UCB.BR
€197.3
0.9%
6
IPH.PA Innate Pharma S.A.
IPH.PA
€2.01
1.9%
5

News

No news articles.

ALBPS.PA Alternative Data

Web Traffic

Biophytis S.A. receives an estimated 1268 monthly visitors to biophytis.com.

  • Web Traffic

    1268

  • Change from Previous Month

    27.4%

  • 3 Month Change

    19.8%

  • YoY Change

    19.8%

Facebook Engagement

Biophytis S.A. has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Job Postings

Biophytis S.A. currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Biophytis S.A. has 1,892 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.

  • Twitter Followers

    1892

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.3%

LinkedIn Followers

4,751 are following Biophytis S.A. on LinkedIn, up by 0.7% over the last month.

  • LinkedIn Followers

    4751

  • Daily Change

    0.7%

  • 1 Month Change

    0.7%

  • 3 Month Change

    2.3%

LinkedIn Employees

According to LinkedIn, Biophytis S.A. has 23 employees.

  • LinkedIn Employees

    23

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

Biophytis S.A. was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Biophytis S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

ALBPS.PA Financials

ALBPS.PA Key Metrics
  • Total Revenue

    €0

  • Net Income

    -€2.9M

  • Earnings per Share

    -€0.83

  • Free cash flow

    -€3K

  • EBITDA

    -€2.1M

  • EBITDA Ratio

    0

  • Total Assets

    €8.7M

ALBPS.PA 2-year Revenue & Income
ALBPS.PA 2-year Free Cash Flow

ALBPS.PA Technicals

ALBPS.PA SMA
ALBPS.PA RSI

FAQ

What's the current price of Biophytis S.A. (ALBPS.PA) Stock?
The price of an Biophytis S.A. (ALBPS.PA) share is €0.176.

What's the market cap of Biophytis S.A.?
The current market cap of Biophytis S.A. is 4.1M.

Should I buy or sell ALBPS.PA?
Biophytis S.A. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Biophytis S.A. is better viewed as a hold or accumulate position while waiting for further developments.

Is Biophytis S.A. a good investment?
The current analysis of Biophytis S.A.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Biophytis S.A.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Biophytis S.A. (ALBPS.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Biophytis S.A. stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Biophytis S.A. (ALBPS.PA) that investors often compare it to?
Biophytis S.A. (ALBPS.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for Biophytis S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Biophytis S.A.'s stock price to be around €0.175 in 2026. Starting from the current price of €0.176, this represents a 0.6% change in price, indicating a neutral outlook for the stock.

How to buy Biophytis S.A. (ALBPS.PA) Stock?
Biophytis S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Biophytis S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.